Page last updated: 2024-09-04

ezetimibe and Diabetes Mellitus

ezetimibe has been researched along with Diabetes Mellitus in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	11 (22.92)	29.6817
2010's	26 (54.17)	24.3611
2020's	11 (22.92)	2.80

Authors

Authors	Studies
Choi, HD; Shin, KH	1
Choi, J; Chung, JW; Hong, JH; Jeon, U; Kim, HD; Kim, W; Park, SH; Seong, K; Shin, WY	1
Hamasaki, A; Hasebe, M; Honjo, S; Iwasaki, K; Iwasaki, Y; Keidai, Y	1
Akiyama, Y; Fujii, H; Harada-Shiba, M; Ishibashi, Y; Ishida, T; Ishigaki, Y; Kabata, D; Kihara, Y; Kotani, K; Kurisu, S; Masuda, D; Matoba, T; Matsuki, K; Matsumura, T; Mori, K; Nakagami, T; Nakazato, M; Shoji, T; Taniuchi, S; Ueno, H; Yamashita, S; Yoshida, H	1
Ahn, CM; Cho, JY; Cho, YH; Choi, D; Hong, MK; Hong, SJ; Im, SW; Jang, Y; Kang, WC; Kim, BK; Kim, JS; Ko, YG; Lee, SJ; Lee, SY; Lee, YH; Lee, YJ; Park, Y; Shin, WY; You, SC; Yun, KH	1
Stone, NJ	1
Blazing, MA; Braunwald, E; Cannon, CP; Giugliano, RP; Lokhnygina, Y; McGuire, DK; Page, CB; Shah, NP; Tershakovec, AM	1
Cho, L	1
Chatterjee, S; Chiu, SW; Feinn, R; Pratt, CM	1
Fras, Z; Mikhailidis, DP	1
Casula, M; Catapano, AL; Pirillo, A; Tokgözoğlu, L	1
Baxter, CA; Davies, GM; Vyas, A	1
El-Barbari, AA; El-Tamalawy, MM; Hassan, TM; Ibrahim, OM	1
Bernik, MMS; Cerda, A; Dorea, EL; Fajardo, CM; Guimarães, ES; Gusukuma, MC; Hirata, MH; Hirata, RDC; Pinto, GA	1
Armitage, J; Herrington, WG; Preiss, D	1
Fox, KM; Han, S; Kim, E; Kim, H; Kim, S; Qian, Y; Rane, PP; Suh, HS; Zhao, Z	1
Bujas-Bobanovic, M; Ganda, OP; Koren, A; Leiter, LA; Letierce, A; Mandel, J; Plutzky, J; Sanganalmath, SK	1
Koh, KK	1
Donzelli, A; Giudicatti, G; Schivalocchi, A	1
Endo, H; Kanazawa, M; Kondo, M; Nakamura, A; Nozaki, E; Sato, K; Takahashi, T	1
Blaha, MJ; Kaluski, E; Khan, MS; Khan, SU; Lincoff, AM; Martin, SS; Okunrintemi, V; Rahman, H; Riaz, H; Sattur, S	1
Bang, LE; Gislason, GH; Høfsten, DE; Jensen, JS; Køber, LV; Pallisgaard, J; Ripa, MS; Schjerning, AM; Theilade, JE; Weeke, PE	1
Ganesan, S; Ito, MK	1
Alexopoulos, D; Davlouros, P; Perperis, A; Siahos, S; Xanthopoulou, I; Zaharioglou, E	1
Almquist, T; Hjemdahl, P; Jacobson, SH; Mobarrez, F; Näsman, P	1
Jain, M; Zafrir, B	1
Ambegaonkar, B; Davies, G; Ejzykowicz, F; Hsu, TY; Laires, PA	1
Elisaf, MS; Filippatos, TD	1
Almquist, T; Hjemdahl, P; Jacobson, SH; Mobarrez, F; Wallén, H	1
Gartlehner, G; Glechner, A; Kaminski-Hartenthaler, A; Mahlknecht, P; Nußbaumer, B	1
Ahn, Y; Chae, IH; Han, KR; Hong, SJ; Hong, TJ; Jeon, DW; Jeon, HK; Kim, HS; Kim, KJ; Kim, SH; Kim, W; Kwak, CH; Lee, N; Moon, KW; Nam, CW; Park, S; Park, TH; Rha, SW; Rhee, MY; Yoon, YW	1
Chen, PY; Chien, KL; Choo, DW; Chou, CH; Ho, W; Lin Wu, FL; Lin, ZF; Wang, J; Wang, YW; Wu, YJ	1
Dresner, J; Shani, M; Vinker, S	1
Camarota, LM; Davies, JP; Gilham, DE; Howles, PN; Hui, DY; Ioannou, YA; Jandacek, RJ; Labonté, ED; Rojas, JC; Tso, P	1
Díaz Gómez, JM	1
Borrego Domínguez, JM; Guisado Rasco, A; Lage Gallé, E; Martínez Martínez, A; Mogollón Jiménez, MV; Sánchez Brotons, JA; Sobrino Márquez, JM	1
Weiss, SH	1
Katsiki, N; Mikhailidis, DP; Sarigianni, M	1
Doggrell, SA	1
Aoki, C; Hattori, Y; Iijima, T; Jojima, T; Kasai, K; Kase, H; Kawagoe, Y; Nakano, A; Ohta, S; Tanaka, S; Tomizawa, A	1
Arca, M; Budal, S; Degli Esposti, E; Degli Esposti, L; Sangiorgi, D; Vigna, GB	1
Füessl, HS	1
Brady, WE; Denke, M; Gazzara, RA; McBride, P; Pearson, T; Tershakovec, AM	1
Bissonnette, S; Boukas, S; Habib, R; Sampalis, JS	1
Aronow, WS; Joseph, J; Koka, M	1
Athyros, VG; Kakafika, AI; Karagiannis, A; Koumaras, H; Mikhailidis, DP; Tziomalos, K	1
Barho, C; Bode, C; Darius, H; Hildemann, S; Karmann, B; Pittrow, D	1

Reviews

8 review(s) available for ezetimibe and Diabetes Mellitus

Article	Year
Comparison of Efficacy and Safety of Statin-Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2022, Volume: 22, Issue:4 Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Diabetes Mellitus; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Treatment Outcome	2022
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Ezetimibe on Risk of New-Onset Diabetes: A Systematic Review and Meta-Analysis of Large, Double-Blinded Randomized Controlled Trials. Journal of cardiovascular pharmacology and therapeutics, 2020, Volume: 25, Issue:5 Topics: Anticholesteremic Agents; Diabetes Mellitus; Double-Blind Method; Dyslipidemias; Ezetimibe; Humans; Incidence; PCSK9 Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Serine Proteinase Inhibitors; Treatment Outcome	2020
Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials. Diabetes, obesity & metabolism, 2018, Volume: 20, Issue:10 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atherosclerosis; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Diabetes Mellitus; Diabetic Angiopathies; Ezetimibe; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome	2018
Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis. Journal of the American Heart Association, 2019, 04-02, Volume: 8, Issue:7 Topics: Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Cholesterol, LDL; Diabetes Mellitus; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; PCSK9 Inhibitors; Randomized Controlled Trials as Topic; Risk Factors	2019
Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications. Cardiovascular drugs and therapy, 2014, Volume: 28, Issue:4 Topics: Animals; Azetidines; Bile Acids and Salts; Blood Glucose; Cholesterol Ester Transfer Proteins; Diabetes Mellitus; Ezetimibe; Fibric Acids; Fish Oils; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Niacin	2014
Ezetimibe-Statin Combination Therapy. Deutsches Arzteblatt international, 2016, Jul-01, Volume: 113, Issue:26 Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Causality; Comorbidity; Death, Sudden, Cardiac; Diabetes Mellitus; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Risk Factors; Survival Rate; Treatment Outcome	2016
[Cardiovascular mortality in kidney transplatation]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2008, Volume: 28 Suppl 5 Topics: Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Comorbidity; Coronary Angiography; Diabetes Mellitus; Dyslipidemias; Ezetimibe; Humans; Kidney Diseases; Kidney Transplantation; Myocardial Ischemia; Obesity; Postoperative Complications; Preoperative Care; Prognosis; Risk Factors	2008
Lowering LDL cholesterol with margarine containing plant stanol/sterol esters: is it still relevant in 2011? Complementary therapies in medicine, 2011, Volume: 19, Issue:1 Topics: Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Ezetimibe; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Margarine; Micronutrients; Niacin; Phytosterols; Sitosterols; Triglycerides	2011

Trials

11 trial(s) available for ezetimibe and Diabetes Mellitus

Article	Year
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial. European heart journal, 2023, 03-14, Volume: 44, Issue:11 Topics: Anticholesteremic Agents; Atherosclerosis; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Treatment Outcome	2023
Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease). Current vascular pharmacology, 2021, Volume: 19, Issue:5 Topics: Aged; Anticholesteremic Agents; Chronic Disease; Diabetes Mellitus; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Male; Non-alcoholic Fatty Liver Disease; Simvastatin; Treatment Outcome	2021
Effect of Combination Therapy of Ezetimibe and Atorvastatin on Remnant Lipoprotein Versus Double Atorvastatin Dose in Egyptian Diabetic Patients. Journal of clinical pharmacology, 2018, Volume: 58, Issue:1 Topics: Anticholesteremic Agents; Apolipoproteins B; Atherosclerosis; Atorvastatin; Cholesterol; Cholesterol, LDL; Diabetes Mellitus; Drug Therapy, Combination; Egypt; Ezetimibe; Female; Gastric Stump; Humans; Lipoproteins; Male; Middle Aged; Prospective Studies; Triglycerides	2018
Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease. European journal of clinical investigation, 2014, Volume: 44, Issue:3 Topics: Aged; Anticholesteremic Agents; Azetidines; Case-Control Studies; Chemokine CCL2; Cross-Over Studies; Diabetes Mellitus; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Inflammation; Inflammation Mediators; Interferon-gamma; Male; Middle Aged; Renal Insufficiency, Chronic; Simvastatin; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1	2014
Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016, Volume: 31, Issue:6 Topics: Aged; Anticholesteremic Agents; Biomarkers; Cardiovascular Diseases; Cell-Derived Microparticles; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Flow Cytometry; Humans; Male; Middle Aged; P-Selectin; Renal Insufficiency, Chronic; Risk Factors; Simvastatin	2016
Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe). Cardiovascular therapeutics, 2016, Volume: 34, Issue:5 Topics: Aged; Anticholesteremic Agents; Biomarkers; Cholesterol, LDL; Diabetes Mellitus; Double-Blind Method; Drug Combinations; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Metabolic Syndrome; Middle Aged; Republic of Korea; Rosuvastatin Calcium; Time Factors; Treatment Outcome; Triglycerides	2016
Effectiveness of a combination of ezetimibe and statins in patients with acute coronary syndrome and multiple comorbidities: A 6-year population-based cohort study. International journal of cardiology, 2017, Apr-15, Volume: 233 Topics: Acute Coronary Syndrome; Aged; Anticholesteremic Agents; Comorbidity; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Population Surveillance; Propensity Score; Survival Rate; Taiwan; Time Factors; Treatment Outcome	2017
Comparative study between high-dose fluvastatin and low-dose fluvastatin and ezetimibe with regard to the effect on endothelial function in diabetic patients. Endocrine journal, 2011, Volume: 58, Issue:3 Topics: Aged; Anticholesteremic Agents; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Ezetimibe; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Male; Middle Aged; Treatment Outcome; Triglycerides; Vasodilation	2011
Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome. Diabetes & vascular disease research, 2006, Volume: 3, Issue:2 Topics: Aged; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Azetidines; C-Reactive Protein; Cholesterol, LDL; Diabetes Mellitus; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Metabolic Syndrome; Middle Aged; Placebos	2006
Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Azetidines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Metabolic Syndrome; Middle Aged; Risk	2007
Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients. The American journal of cardiology, 2008, Feb-15, Volume: 101, Issue:4 Topics: Anticholesteremic Agents; Atorvastatin; Azetidines; Cholesterol, LDL; Coronary Artery Disease; Creatinine; Diabetes Mellitus; Drug Administration Schedule; Drug Therapy, Combination; Ezetimibe; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Peripheral Vascular Diseases; Prospective Studies; Pyrroles; Stroke	2008

Other Studies

29 other study(ies) available for ezetimibe and Diabetes Mellitus

Article	Year
A Paradigm Shift in Dyslipidemia Management in Primary Care: A 12-Month Cohort Study. Clinical therapeutics, 2022, Volume: 44, Issue:5 Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Diabetes Mellitus; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Primary Health Care; Rosuvastatin Calcium	2022
Plant sterol hyperabsorption caused by uncontrolled diabetes in a patient with a heterozygous ABCG5 variant. Journal of diabetes investigation, 2022, Volume: 13, Issue:11 Topics: ATP Binding Cassette Transporter, Subfamily G, Member 5; Diabetes Mellitus; Ezetimibe; Humans; Hypercholesterolemia; Intestinal Diseases; Lipid Metabolism, Inborn Errors; Lipoproteins; Phytosterols	2022
Relationship between Diabetes Mellitus and Serum Lathosterol and Campesterol Levels: The CACHE Study DM Analysis. Journal of atherosclerosis and thrombosis, 2023, Jul-01, Volume: 30, Issue:7 Topics: Biomarkers; Cholesterol; Diabetes Mellitus; Ezetimibe; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Phytosterols	2023
RACING to judgement: weighing the value of pre-specified subgroup analyses. European heart journal, 2023, 03-14, Volume: 44, Issue:11 Topics: Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Judgment	2023
Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT. Journal of the American Heart Association, 2023, 07-04, Volume: 12, Issue:13 Topics: Anticholesteremic Agents; Diabetes Mellitus; Drug Therapy, Combination; Ezetimibe; Hydroxymethylglutaryl-CoA Reductase Inhibitors	2023
A practical approach to the cholesterol guidelines and ASCVD prevention. Cleveland Clinic journal of medicine, 2020, Volume: 87, Issue:5 suppl 1 Topics: Age Factors; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atherosclerosis; Autoimmune Diseases; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; PCSK9 Inhibitors; Practice Guidelines as Topic; Primary Prevention; Risk Assessment; Risk Reduction Behavior; Secondary Prevention; Vascular Calcification	2020
Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular risk. Atherosclerosis. Supplements, 2020, Volume: 42 Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus; Europe; Ezetimibe; Heart Disease Risk Factors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; PCSK9 Inhibitors; Practice Guidelines as Topic; Primary Prevention; Renal Insufficiency, Chronic; United States	2020
Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States. Journal of medical economics, 2017, Volume: 20, Issue:7 Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol, LDL; Coronary Disease; Cost-Benefit Analysis; Diabetes Mellitus; Drug Therapy, Combination; Ezetimibe; Fees, Pharmaceutical; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Markov Chains; Middle Aged; Models, Economic; Quality-Adjusted Life Years; Stroke; United States	2017
Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients. Cardiovascular therapeutics, 2017, Volume: 35, Issue:6 Topics: Adipokines; Adult; Aged; Anticholesteremic Agents; Biomarkers; Blood Glucose; Cytokines; Diabetes Mellitus; Dyslipidemias; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Male; Middle Aged; Monocytes; RNA, Messenger; Simvastatin	2017
Ezetimibe: Likely to Be Beneficial For All. Circulation, 2018, 04-10, Volume: 137, Issue:15 Topics: Anticholesteremic Agents; Cholesterol, LDL; Diabetes Mellitus; Ezetimibe; Ezetimibe, Simvastatin Drug Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors	2018
Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-based Study in South Korea. Clinical therapeutics, 2018, Volume: 40, Issue:6 Topics: Aged; Anticholesteremic Agents; Atherosclerosis; Databases, Factual; Diabetes Mellitus; Drug Utilization; Ezetimibe; Female; Humans; Lipids; Male; Medication Adherence; Middle Aged; Republic of Korea; Retrospective Studies	2018
Letter by Koh Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy Internationa Circulation, 2018, 10-23, Volume: 138, Issue:17 Topics: Anticholesteremic Agents; Diabetes Mellitus; Ezetimibe; Ezetimibe, Simvastatin Drug Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors	2018
Letter by Donzelli et al Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy I Circulation, 2018, 10-23, Volume: 138, Issue:17 Topics: Anticholesteremic Agents; Diabetes Mellitus; Ezetimibe; Ezetimibe, Simvastatin Drug Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors	2018
Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabetic-metabolic syndrome patients with coronary artery disease. Heart and vessels, 2019, Volume: 34, Issue:6 Topics: Aged; Blood Glucose; Coronary Artery Disease; Diabetes Mellitus; Ezetimibe; Female; Humans; Hyperlipidemias; Insulin; Insulin Resistance; Linear Models; Male; Metabolic Syndrome; Middle Aged; Obesity; Postprandial Period; Prospective Studies; Triglycerides	2019
Clinical characteristics and lipid lowering treatment of patients initiated on proprotein convertase subtilisin-kexin type 9 inhibitors: a nationwide cohort study. BMJ open, 2019, 04-01, Volume: 9, Issue:4 Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Denmark; Diabetes Mellitus; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Myocardial Ischemia; PCSK9 Inhibitors; Practice Patterns, Physicians'; Stroke	2019
Coenzyme Q10 ameliorates the reduction in GLUT4 transporter expression induced by simvastatin in 3T3-L1 adipocytes. Metabolic syndrome and related disorders, 2013, Volume: 11, Issue:4 Topics: 3T3-L1 Cells; Adipocytes; Animals; Anticholesteremic Agents; Azetidines; Diabetes Mellitus; Drug Interactions; Ezetimibe; Glucose Transporter Type 4; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Mice; Pravastatin; Simvastatin; Ubiquinone	2013
First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients. Lipids in health and disease, 2013, Nov-09, Volume: 12 Topics: Aged; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Drug Administration Schedule; Drug Therapy, Combination; Ezetimibe; Female; Greece; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Outpatients; Prospective Studies; Risk Assessment; Treatment Outcome; Urban Population	2013
Cost-effectiveness of adding ezetimibe to atorvastatin vs switching to rosuvastatin therapy in Portugal. Journal of medical economics, 2015, Volume: 18, Issue:8 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Coronary Disease; Cost-Benefit Analysis; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Female; Humans; Lipids; Male; Middle Aged; Portugal; Quality-Adjusted Life Years; Risk Factors; Rosuvastatin Calcium; Smoking	2015
Statin-Ezetimibe Combination Therapy In Diabetic Individuals. Angiology, 2016, Volume: 67, Issue:6 Topics: Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Diabetes Mellitus; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia	2016
Achieving target cholesterol levels in diabetic patients: potency of the statin or potency of the physician? The Israel Medical Association journal : IMAJ, 2008, Volume: 10, Issue:5 Topics: Aged; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Diabetes Mellitus; Dose-Response Relationship, Drug; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Israel; Male; Middle Aged; Patient Compliance	2008
Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice. American journal of physiology. Gastrointestinal and liver physiology, 2008, Volume: 295, Issue:4 Topics: Animals; Azetidines; Diabetes Mellitus; Dietary Carbohydrates; Dietary Fats; Ezetimibe; Fatty Acid Transport Proteins; Fatty Acids; Female; Hyperglycemia; Intestinal Absorption; Male; Membrane Transport Proteins; Mice; Obesity	2008
Safety and efficacy of ezetimibe in a sample of cardiac transplant patients. Transplantation proceedings, 2008, Volume: 40, Issue:9 Topics: Aged; Alanine Transaminase; Anticholesteremic Agents; Aspartate Aminotransferases; Azetidines; Bilirubin; Cholesterol; Diabetes Mellitus; Dose-Response Relationship, Drug; Dyslipidemias; Ezetimibe; Heart Transplantation; Humans; Hypertension; Immunosuppressive Agents; Middle Aged; Retrospective Studies; Safety; Triglycerides	2008
Niacin compared with ezetimibe. The New England journal of medicine, 2010, Mar-18, Volume: 362, Issue:11 Topics: Anticholesteremic Agents; Azetidines; Blood Glucose; Carotid Arteries; Coronary Disease; Diabetes Mellitus; Drug Therapy, Combination; Ezetimibe; Humans; Niacin; Patient Dropouts; Research Design	2010
Ezetimibe in diabetes: more than cholesterol lowering? Current medical research and opinion, 2010, Volume: 26, Issue:10 Topics: Anticholesteremic Agents; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Combinations; Ezetimibe; Humans; Randomized Controlled Trials as Topic; Simvastatin	2010
[Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study]. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2011, Volume: 76, Issue:4 Topics: Aged; Algorithms; Azetidines; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol, LDL; Cohort Studies; Diabetes Complications; Diabetes Mellitus; Ezetimibe; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Italy; Lovastatin; Male; Medication Adherence; Middle Aged; Pravastatin; Pyrimidines; Retrospective Studies; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome	2011
[MMW- Drug Prize 2005 for simvastatin/ezetimib (Inegy). LDL goal values are easier to reach now]. MMW Fortschritte der Medizin, 2005, Oct-27, Volume: 147, Issue:43 Topics: Aged; Anticholesteremic Agents; Awards and Prizes; Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus; Drug Combinations; Ezetimibe; Female; Germany; Humans; Male; Periodicals as Topic; Risk Factors; Simvastatin	2005
Prevalence of adequate and of optimal control of serum low-density lipoprotein cholesterol in an academic nursing home. Journal of the American Medical Directors Association, 2007, Volume: 8, Issue:9 Topics: Academic Medical Centers; Aged; Aged, 80 and over; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Coronary Artery Disease; Diabetes Mellitus; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nursing Homes; Peripheral Vascular Diseases; Risk Assessment; Risk Factors	2007
Mismanaged measures. Nature, 2008, Apr-03, Volume: 452, Issue:7187 Topics: Atherosclerosis; Azetidines; Biomarkers; Cholesterol; Clinical Trials as Topic; Diabetes Mellitus; Ezetimibe; Humans; Reproducibility of Results; Treatment Outcome	2008
Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary care. Current medical research and opinion, 2008, Volume: 24, Issue:6 Topics: Aged; Ambulatory Care; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus; Ezetimibe; Female; Forecasting; Humans; Hypercholesterolemia; Male; Middle Aged; Primary Health Care; Prospective Studies; Risk Assessment; Simvastatin; Treatment Outcome	2008